Gradientech is a Swedish in vitro diagnostics company specializing in ultra-fast antibiotic susceptibility testing (AST). Their flagship product, QuickMIC®, is designed to empower modern microbiology laboratories by delivering accurate minimum inhibitory concentration (MIC) values directly from positive blood cultures within 2-4 hours. The technology enables faster and more informed treatment decisions, improving healthcare and reducing the spread of antibiotic resistance.
Gradientech offers QuickMIC®, an ultra-rapid AST (Antimicrobial Susceptibility Testing) system that provides precise MIC (Minimum Inhibitory Concentration) values directly from positive blood cultures within 2–4 hours. The system utilizes microfluidics and live imaging to monitor bacterial growth along a linear antibiotic concentration gradient. QuickMIC® is CE-marked for use within the EU and is employed in clinical laboratories to enable faster and more accurate treatment decisions for sepsis and other severe infections.
Gradientech generates revenue through the sale of the QuickMIC® system, including single-use test cassettes and accompanying software. The company focuses on offering scalable and user-friendly solutions for clinical laboratories, with modular instruments that can be stacked to increase throughput based on demand.
Gradientech has expanded its operations by establishing partnerships and a distribution network across Europe and North America. The company has received CE-IVD approval for QuickMIC® and is conducting clinical studies to support regulatory submissions in additional markets. Gradientech continues to invest in research and development to enhance and broaden its diagnostic offerings.
Here's how it works:
Here's how it works:
.avif)
.png)
.png)
.avif)